Multiple sclerosis, Guillain-Barré syndrome and myelin basic protein-specific cellular antibody

Anne B. Johnson*, Mauro Carlo Dal Canto

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

5 Scopus citations


MULTIPLE sclerosis (MS) and the Guillain-Barré syndrome (GBS) are demyelinating diseases of improven aetiology and pathogenesis, in which infectious and immunological factors have been suggested to have a role 1-3. The notion that sensitisation to basic proteins from myelin might be involved has arisen from certain similarities between these human diseases and the autoimmune demyelinating diseases of animals, experimental allergic encephalomyelitis (EAE) and experimental allergic neuritis (EAN) 4. EAE is caused by sensitisation to the encephalitogenic basic protein from central myelin (CNS-BP) and EAN by sensitisation to peripheral myelin. One of the two basic proteins of peripheral myelin, P2 protein 5, is considered a likely candidate for the neuritogenic factor 6. To help determine whether sensitisation to myelin basic proteins is involved in the pathogenesis of MS and GBS, we have used horseradish peroxidase (HRP)-labelled myelin basic proteins7,8 to seek evidence of an antibody of this specificity in nervous system plasma cells in these diseases. Our negative findings do not support a pathogenetic role for myelin basic proteins in MS or GBS.

Original languageEnglish (US)
Pages (from-to)453-454
Number of pages2
Issue number5585
StatePublished - Dec 1 1976

ASJC Scopus subject areas

  • General


Dive into the research topics of 'Multiple sclerosis, Guillain-Barré syndrome and myelin basic protein-specific cellular antibody'. Together they form a unique fingerprint.

Cite this